Published in Endocrinology on October 01, 2002
Androgens and bone. Steroids (2008) 1.05
Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res (2006) 0.97
Reduced bone mass and muscle strength in male 5α-reductase type 1 inactivated mice. PLoS One (2011) 0.85
Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther (2009) 0.83
The endocrine role of estrogens on human male skeleton. Int J Endocrinol (2015) 0.80
The effect of orchidectomy on thyroid C cells and bone histomorphometry in middle-aged rats. Histochem Cell Biol (2007) 0.78
Genetic regulation of the growth plate. Front Endocrinol (Lausanne) (2012) 0.77
The effects of delayed puberty on the growth plate. J Pediatr Orthop (2013) 0.76
Androgen receptors and experimental bone loss - an in vivo and in vitro study. Bone (2015) 0.75
Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up. Endocr Rev (2015) 0.75
Glucosamine and chondroitin sulfate association increases tibial epiphyseal growth plate proliferation and bone formation in ovariectomized rats. Clinics (Sao Paulo) (2014) 0.75
Genomic and non-genomic actions of sex steroids in the growth plate. Pediatr Nephrol (2005) 0.75
PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33
Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res (2000) 4.41
The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res (1998) 3.13
Body index measurements in 1996-7 compared with 1980. Arch Dis Child (2000) 2.77
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab (2008) 2.74
Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology (2000) 2.51
Developing evidence-based guidelines for referral for short stature. Arch Dis Child (2007) 2.49
Systemic and local regulation of the growth plate. Endocr Rev (2003) 2.14
[Measuring the length of newborn infants]. Ned Tijdschr Geneeskd (2005) 1.94
Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum (2012) 1.84
Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants? Early Hum Dev (2003) 1.66
Towards evidence based referral criteria for growth monitoring. Arch Dis Child (2004) 1.59
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab (2001) 1.51
Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res (2002) 1.49
Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res (1998) 1.47
A 43-year-old male with untreated panhypopituitarism due to absence of the pituitary stalk: from dwarf to giant. J Clin Endocrinol Metab (2002) 1.46
Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science (1992) 1.45
Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res (2000) 1.42
Pubertal development in The Netherlands 1965-1997. Pediatr Res (2001) 1.40
[Clinical characteristics and management of adolescents admitted to the emergency ward for alcohol intoxication in the region of The Hague during the period 1999-2001]. Ned Tijdschr Geneeskd (2004) 1.39
The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res (1998) 1.39
Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature. Dutch Growth Hormone Working Group. Clin Endocrinol (Oxf) (1995) 1.39
Catch-up growth. Endocr Rev (1997) 1.38
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
A method to construct age references for skewed skinfold data, using Box-Cox transformations to normality. Hum Biol (1985) 1.32
Nationwide age references for sitting height, leg length, and sitting height/height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child (2005) 1.31
Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands. Acta Paediatr (2004) 1.23
Outer-membrane PhoE protein of Escherichia coli K-12 as an exposure vector: possibilities and limitations. Gene (1990) 1.23
Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis. J Med Genet (2008) 1.20
An analysis of intra-uterine growth retardation in rural Malawi. Eur J Clin Nutr (2001) 1.19
[Increased prevalence of overweight and obesity in Dutch children, and the detection of overweight and obesity using international criteria and new reference diagrams]. Ned Tijdschr Geneeskd (2001) 1.18
Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J Bone Miner Res (2000) 1.17
Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases. Analysis of clinical features, growth and plasma somatomedin. Eur J Pediatr (1985) 1.13
Gene expression profiling of dedifferentiated human articular chondrocytes in monolayer culture. Osteoarthritis Cartilage (2013) 1.13
Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group. Acta Paediatr (1998) 1.12
Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect Tissue Res (2007) 1.11
Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr (1997) 1.10
Growth of preterm born children. Horm Res (2008) 1.10
Synthesis and characterization of hyaluronic acid-poly(ethylene glycol) hydrogels via Michael addition: An injectable biomaterial for cartilage repair. Acta Biomater (2009) 1.09
Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. Am J Pathol (2001) 1.08
Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol (Oxf) (2007) 1.08
High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child (2002) 1.06
Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes. J Invest Dermatol (2000) 1.05
The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab (2013) 1.05
Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor. J Intern Med (2006) 1.04
Activation of junB by PKC and PKA signal transduction through a novel cis-acting element. Nucleic Acids Res (1991) 1.04
Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms. Arch Dis Child (2004) 1.04
Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet (1993) 1.04
Defects in growth hormone receptor signaling. Trends Endocrinol Metab (2007) 1.04
Prepubertal height velocity references over a wide age range. Arch Dis Child (1992) 1.03
High throughput generated micro-aggregates of chondrocytes stimulate cartilage formation in vitro and in vivo. Eur Cell Mater (2012) 1.03
Genetic disorders in the growth hormone - insulin-like growth factor-I axis. Horm Res (2006) 1.03
Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia (2006) 1.01
Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone (2001) 1.01
Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. J Clin Endocrinol Metab (2009) 1.01
The rat, mouse and human genes encoding the receptor for parathyroid hormone and parathyroid hormone-related peptide are highly homologous. Biochem Biophys Res Commun (1994) 1.00
Adult height in patients with early onset of Crohn's disease. Gut (2002) 0.99
Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant (2004) 0.99
A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. J Clin Endocrinol Metab (2006) 0.99
Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab (2001) 0.99
Intelligence of very preterm or very low birthweight infants in young adulthood. Arch Dis Child Fetal Neonatal Ed (2008) 0.98
Genetic disorders in the GH IGF-I axis in mouse and man. Eur J Endocrinol (2007) 0.98
Immunologic studies in Turner syndrome before and during treatment with growth hormone. The Dutch Growth Hormone Working Group. J Pediatr (1991) 0.98
Genetic analysis of short stature. Horm Res (2003) 0.97
Treatment with two growth hormone regimens in girls with Turner syndrome: final height results. Dutch Growth Hormone Working Group. Horm Res (1995) 0.96
Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res (1998) 0.96
Growth curves of Dutch children with Down's syndrome. J Intellect Disabil Res (1996) 0.96
[Growth diagrams for patient care]. Tijdschr Kindergeneeskd (1985) 0.96
Quality of life in short adults. Horm Res (1998) 0.96
Mutations in mitochondrial tRNA genes: non-linkage with syndromes of Wolfram and chronic progressive external ophthalmoplegia. Nucleic Acids Res (1992) 0.95
Parathyroid hormone-related peptide as an endogenous inducer of parietal endoderm differentiation. J Cell Biol (1993) 0.95
Growth monitoring and diagnostic work-up of short stature: an international inventorization. J Pediatr Endocrinol Metab (2005) 0.94
Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr (1994) 0.94
Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Biomaterials (2010) 0.94
Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients. Arch Dis Child (2002) 0.93
Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody. Int J Cancer (2013) 0.92
Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet (1991) 0.92
Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway. Mol Cell Biochem (2005) 0.92
Final height after long-term growth hormone treatment in Turner syndrome. European Study Group. J Pediatr (1995) 0.92
Catch-up growth and endocrine changes in childhood celiac disease. Endocrine changes during catch-up growth. Horm Res (2002) 0.91
Testicular degeneration in three patients with the persistent müllerian duct syndrome. Eur J Pediatr (1995) 0.91
The offspring of mothers with anorexia nervosa: a high-risk group for undernutrition and stunting? Eur J Pediatr (1989) 0.91
Inhibition of Gsk3β in cartilage induces osteoarthritic features through activation of the canonical Wnt signaling pathway. Osteoarthritis Cartilage (2011) 0.90
Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone. J Clin Endocrinol Metab (1996) 0.90
Tall stature and duplication of the insulin-like growth factor I receptor gene. Eur J Med Genet (2006) 0.89
Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr (2000) 0.89
Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum (2004) 0.89
Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group. Eur J Pediatr (1992) 0.89
Polymorphic detection of a parthenogenetic maternal and double paternal contribution to a 46,XX/46,XY hermaphrodite. Am J Hum Genet (1998) 0.89
Mutations in the NSD1 gene in patients with Sotos syndrome associate with endocrine and paracrine alterations in the IGF system. Eur J Endocrinol (2004) 0.88
The effect of oestrogen treatment on body proportions in constitutionally tall girls. Eur J Pediatr (1994) 0.88